Skip to main content
OpenTrials
Completed

NCT Number: NCT01423097

Magnitude of Osteoarthritis disadVantage on pEoples liveS

Estimate the prevalence of self-reported osteoarthritis and its characterization in adults over 45 years of age:

* Characterization of self-reported patients with OA (socio-demographic, comorbidities, VAS for intensity of pain) * Characterization of OA diagnosis in patients with self-reported OA * Impact of self-reported OA in the working abilities, quality of life and functionality (SF-12 v2.0) * Characterization of treatment approaches (therapeutic and non-therapeutic) for self-reported patients with OA * Patient perception of impact of OA in its life and importance given to disease

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases

Age range

45 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site

Queluz Baixo, Barcarena, Portugal

About this study

Magnitude of Osteoarthritis disadvantage on peoples lives.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults over 45 years old with self-reported osteoarthritis

Exclusion criteria

  • NA

Treatment and study plan

Primary outcomes

  1. Estimate the prevalence of self-reported osteoarthritis (OA) in adults over 45 years of age by direct interview.

    Time frame: Single interview at the only one patient contact

Secondary outcomes

  1. Characterization of self-reported patients with OA by collecting socio-demographic information through direct interview.

    Time frame: Single interview at the only one patient contact

  2. Characterization of self-reported patients with OA by collecting comorbidities information through direct interview.

    Time frame: Single interview at the only one patient contact

  3. Characterization of self-reported patients with OA by collecting information for intensity of pain through direct interview.

    Time frame: Single interview at the only one patient contact

  4. Characterization of OA diagnosis in patients with self-reported OA by direct interview.

    Time frame: Single interview at the only one patient contact

  5. Impact of self-reported OA in the working abilities, quality of life and functionality using Questionnaire SF-12 v2.0

    Time frame: Single interview at the only one patient contact

  6. Patient perception of impact of OA in its life and importance given to disease by direct interview.

    Time frame: Single interview at the only one patient contact

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: MOVES

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Aug 25, 2011
Registry last updated
Oct 10, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.